HR 4392
115th Congress
House
Health
Administrative law and regulatory procedures
Department of Health and Human Services
Health care costs and insurance
Home and outpatient care
Hospital care
Inflation and prices
Medicare
Prescription drugs
To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes.
Introduced: November 14, 2017
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 17, 2017
Referred to the Subcommittee on Health.
Nov 14, 2017
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Nov 14, 2017
Introduced in House
Plain-English summary
This bill nullifies a rule finalized by the Centers for Medicare & Medicaid Services on November 13, 2017, that modifies payment under Medicare for certain drugs purchased through the 340B discount program.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
3